Psychopharmacology: Essential Updates for Mental Health Professionals (HS - CARTER - 057520)
Tracking # 20-795665
Course overview
If you are like a lot of therapists, many of your clients are taking psychotropic medicines prescribed by a number of different health care professionals. Despite who wrote the script, it is your responsibility to know your clients' symptoms and reactions to medications, and to coordinate their care. This intensive focuses on providing practical and useful information about antidepressants, anti-anxiety medications, and medication for insomnia, as well as the tools to handle the ethical decisions that surround psychopharmacology. Get to the "bottom line" on the most prescribed antidepressants, anti-anxiety medications, and medication for insomnia on the market today, and learn how to discuss scope of practice with your patients in order to optimize their care. The goal is for you to leave better prepared to communicate with your clients as well as the prescribers.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Certified Master Social Worker
Licensed Clinical Social Worker
Licensed Marriage and Family Therapist
Licensed Mental Health Counselor
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Florida Board of Psychology
Limited License Psychologist
Psychologist
Florida Office of School Psychology
School Psychologist
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Licensed Independent Marriage and Family Therapist
Licensed Independent Social Worker
Licensed Professional Clinical Counselor
Licensed Professional Counselor
Licensed Social Worker
Marriage and Family Therapist
Registered Social Worker Assistant
Disclosure statements
Financial: Dr. Kenneth Carter is a professor at Oxford College of Emory University. He receives a speaking honorarium from PESI, Inc.
Non-financial: Dr. Kenneth Carter has no relevant non-financial relationship to disclose.